Tag: Eli Lilly and Co

Eli Lilly blows past quarterly estimates, hikes outlook as Zepbound and Mounjaro sales skyrocket

More than 20,000 people are taking Eli Lilly’s weight loss pill Foundayo, CEO says

Pharma bets a little-known form of cholesterol will underpin its next blockbuster heart drugs

‘Mag 7’ earnings, Fed meeting will test a stock market near all-time highs. Here’s what’s ahead

Amazon launches GLP-1 weight loss program, promising ‘fast, convenient’ access

UnitedHealth tops quarterly estimates, hikes profit outlook as insurer manages high medical costs

Eli Lilly agrees to acquire cancer drug maker Kelonia in deal worth up to $7 billion

Here’s our monthly update on all 31 portfolio stocks, including 3 on the buy list

Trump policies, China’s biotech boom are ending Europe’s pharma powerhouse era

As millions lose weight on GLP-1s, they’re starting to turn to retailers to refresh their wardrobes